Cargando…

Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice

BACKGROUND: GPs frequently use 10-year-risk estimations of cardiovascular disease (CVD) to identify high- risk patients. AIM: To assess the performance of four models for predicting the 10-year risk of CVD in Dutch general practice. DESIGN AND SETTING: Prospective cohort study. Routine data (2009– 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoofs, Merle CA, Akkermans, Reinier P, de Grauw, Wim JC, Schalk, Bianca WM, van Dis, Ineke, Tjin-A-Ton, Judith, Bischoff, Erik WMA, Biermans, Marion CJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710862/
https://www.ncbi.nlm.nih.gov/pubmed/36443066
http://dx.doi.org/10.3399/BJGP.2021.0726
_version_ 1784841452513132544
author Schoofs, Merle CA
Akkermans, Reinier P
de Grauw, Wim JC
Schalk, Bianca WM
van Dis, Ineke
Tjin-A-Ton, Judith
Bischoff, Erik WMA
Biermans, Marion CJ
author_facet Schoofs, Merle CA
Akkermans, Reinier P
de Grauw, Wim JC
Schalk, Bianca WM
van Dis, Ineke
Tjin-A-Ton, Judith
Bischoff, Erik WMA
Biermans, Marion CJ
author_sort Schoofs, Merle CA
collection PubMed
description BACKGROUND: GPs frequently use 10-year-risk estimations of cardiovascular disease (CVD) to identify high- risk patients. AIM: To assess the performance of four models for predicting the 10-year risk of CVD in Dutch general practice. DESIGN AND SETTING: Prospective cohort study. Routine data (2009– 2019) was used from 46 Dutch general practices linked to cause of death statistics. METHOD: The outcome measures were fatal CVD for SCORE and first diagnosis of fatal or non- fatal CVD for SCORE fatal and non-fatal (SCORE- FNF), Globorisk-laboratory, and Globorisk-office. Model performance was assessed by examining discrimination and calibration. RESULTS: The final number of patients for risk prediction was 1981 for SCORE and SCORE-FNF, 3588 for Globorisk-laboratory, and 4399 for Globorisk- office. The observed percentage of events was 18.6% (n = 353) for SCORE- FNF, 6.9% (n = 230) for Globorisk-laboratory, 7.9% (n = 323) for Globorisk-office, and 0.3% (n = 5) for SCORE. The models showed poor discrimination and calibration. The performance of SCORE could not be examined because of the limited number of fatal CVD events. SCORE-FNF, the model that is currently used for risk prediction of fatal plus non-fatal CVD in Dutch general practice, was found to underestimate the risk in all deciles of predicted risks. CONCLUSION: Wide eligibility criteria and a broad outcome measure contribute to the model applicability in daily practice. The restriction to fatal CVD outcomes of SCORE renders it less usable in routine Dutch general practice. The models seriously underestimate the 10-year risk of fatal plus non-fatal CVD in Dutch general practice. The poor model performance is possibly because of differences between patients that are eligible for risk prediction and the population that was used for model development. In addition, selection of higher-risk patients for CVD risk assessment by GPs may also contribute to the poor model performance.
format Online
Article
Text
id pubmed-9710862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-97108622022-12-08 Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice Schoofs, Merle CA Akkermans, Reinier P de Grauw, Wim JC Schalk, Bianca WM van Dis, Ineke Tjin-A-Ton, Judith Bischoff, Erik WMA Biermans, Marion CJ Br J Gen Pract Research BACKGROUND: GPs frequently use 10-year-risk estimations of cardiovascular disease (CVD) to identify high- risk patients. AIM: To assess the performance of four models for predicting the 10-year risk of CVD in Dutch general practice. DESIGN AND SETTING: Prospective cohort study. Routine data (2009– 2019) was used from 46 Dutch general practices linked to cause of death statistics. METHOD: The outcome measures were fatal CVD for SCORE and first diagnosis of fatal or non- fatal CVD for SCORE fatal and non-fatal (SCORE- FNF), Globorisk-laboratory, and Globorisk-office. Model performance was assessed by examining discrimination and calibration. RESULTS: The final number of patients for risk prediction was 1981 for SCORE and SCORE-FNF, 3588 for Globorisk-laboratory, and 4399 for Globorisk- office. The observed percentage of events was 18.6% (n = 353) for SCORE- FNF, 6.9% (n = 230) for Globorisk-laboratory, 7.9% (n = 323) for Globorisk-office, and 0.3% (n = 5) for SCORE. The models showed poor discrimination and calibration. The performance of SCORE could not be examined because of the limited number of fatal CVD events. SCORE-FNF, the model that is currently used for risk prediction of fatal plus non-fatal CVD in Dutch general practice, was found to underestimate the risk in all deciles of predicted risks. CONCLUSION: Wide eligibility criteria and a broad outcome measure contribute to the model applicability in daily practice. The restriction to fatal CVD outcomes of SCORE renders it less usable in routine Dutch general practice. The models seriously underestimate the 10-year risk of fatal plus non-fatal CVD in Dutch general practice. The poor model performance is possibly because of differences between patients that are eligible for risk prediction and the population that was used for model development. In addition, selection of higher-risk patients for CVD risk assessment by GPs may also contribute to the poor model performance. Royal College of General Practitioners 2022-11-29 /pmc/articles/PMC9710862/ /pubmed/36443066 http://dx.doi.org/10.3399/BJGP.2021.0726 Text en © The Authors https://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Research
Schoofs, Merle CA
Akkermans, Reinier P
de Grauw, Wim JC
Schalk, Bianca WM
van Dis, Ineke
Tjin-A-Ton, Judith
Bischoff, Erik WMA
Biermans, Marion CJ
Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
title Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
title_full Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
title_fullStr Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
title_full_unstemmed Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
title_short Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
title_sort performance of the score and globorisk cardiovascular risk prediction models: a prospective cohort study in dutch general practice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710862/
https://www.ncbi.nlm.nih.gov/pubmed/36443066
http://dx.doi.org/10.3399/BJGP.2021.0726
work_keys_str_mv AT schoofsmerleca performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice
AT akkermansreinierp performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice
AT degrauwwimjc performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice
AT schalkbiancawm performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice
AT vandisineke performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice
AT tjinatonjudith performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice
AT bischofferikwma performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice
AT biermansmarioncj performanceofthescoreandgloboriskcardiovascularriskpredictionmodelsaprospectivecohortstudyindutchgeneralpractice